N.J. Teen on Front Line of Autism Clinical Trial

Rebecca Singer is participating
in a clinical trial.

She lives in a world no one else can enter, unable to speak or interact with others. But 16-year-old Rebecca Singer may be playing an important role in science.
Rebecca Singer, 16, is taking injections of a promising growth factor hormone that was shown to reverse in mice some of the deficits associated with autism
 Rebecca has become the first patient in a clinical trial testing a drug that researchers hope could pull her out of her reality and eventually lead to a groundbreaking autism treatment.